The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders.
about
Clinical predictors of antipsychotic use in children and adolescents with autism spectrum disorders: a historical open cohort study using electronic health records.Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsCohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resourceCardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial.Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.Quo Vadis Clozapine? A Bibliometric Study of 45 Years of Research in International Context.Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in IcelandAuthors' reply - Clozapine for mitochondrial psychosis.Transformation of excess mortality in people with schizophrenia and bipolar disorder in Taiwan.Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care.Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile and treatment outcomes for clients on clozapine.Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections.Autoimmune and other acquired neutropenias.Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis.Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders.Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.Clozapine treatment and discontinuation in Iceland: A national longitudinal study using electronic patient records.Big data in mental health research - do the ns justify the means? Using large data-sets of electronic health records for mental health research.Real-world effectiveness of antipsychotics.Identification of the delivery of cognitive behavioural therapy for psychosis (CBTp) using a cross-sectional sample from electronic health records and open-text information in a large UK-based mental health case register.Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up.The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health Records.Ethnic minority inequalities in access to treatments for schizophrenia and schizoaffective disorders: findings from a nationally representative cross-sectional study.Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.Risk Evaluation and Mitigation Strategy for Clozapine
P2860
Q27319678-2C916E5C-B69E-4172-9DD1-998C2CC8BC33Q28079065-E82FD5D9-C647-4CC2-BB9B-45ED172D3CFCQ28603024-B615D065-1190-4130-AF31-313F631E373DQ30949176-10D1A5A4-71B6-4C1C-8685-BB6F4EC000DEQ30981989-EB2C0A2F-5614-4973-BE59-31E007E08F4AQ34544343-461EDF92-33DA-4121-AD58-A0F3A20C30F3Q36184331-18CD6C80-2279-4C64-8239-5096B24D6D26Q36220897-C29EF35F-D0BE-46B8-90B2-9E0619D76B11Q37629165-CE4E0E1A-6BAA-4F0A-9EFF-D5A100D0BA26Q38401379-F215EF50-B860-4F23-ABBA-5FAE30F18462Q38469831-91B051E3-6D18-4F4F-80D6-55526FC82437Q38737194-5DD15111-5EE0-4B96-A649-B729D4093041Q38840211-D4FB3A86-1866-4A5D-8D80-EBEA373D1DD4Q38944607-21AF768D-AA61-4313-A242-94F737F8A7C9Q38948365-8E8D02DA-DE5C-4918-849B-2573528A9699Q39027690-4CD702F0-0E07-4E98-966C-1D83E36CFA61Q39233778-81F14B7E-B18D-4B69-88CC-673B8BBA94B0Q39446350-F8B65EAC-105E-4286-8E98-6A5FE13A4A83Q39745540-82DE6D53-ABDD-4F9D-8A3C-2EFF2A433523Q40082921-FCF6EDBB-2415-46D9-95AF-0311CFDE5B0DQ40815632-A61CDB08-C812-4077-8C8C-05748A20BA27Q42344427-A262B8E4-74D9-4E6B-BD6C-1C396C2686E4Q42374185-7CFDD908-7594-46C6-AE1B-25BA3A7BF9EDQ47120615-C89B1AAF-FF22-41B5-A23C-8C50CE263A20Q47258573-E843F419-CD73-49BA-BB48-702563C8A8FBQ47575740-0EAD52E7-80E9-46A8-992D-369295A27475Q53694040-A1388BCD-48D9-4ACB-B3CE-265313C5266FQ55232340-BA1E506B-6362-4373-89E1-18BA774CD7C2Q57820161-83D6E83D-760D-4E06-9EC8-7CEE7B680AFB
P2860
The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The effect of clozapine on pre ...... d other potential confounders.
@ast
The effect of clozapine on pre ...... d other potential confounders.
@en
type
label
The effect of clozapine on pre ...... d other potential confounders.
@ast
The effect of clozapine on pre ...... d other potential confounders.
@en
prefLabel
The effect of clozapine on pre ...... d other potential confounders.
@ast
The effect of clozapine on pre ...... d other potential confounders.
@en
P2093
P2860
P50
P356
P1476
The effect of clozapine on pre ...... d other potential confounders.
@en
P2093
Chin-Kuo Chang
Hitesh Shetty
Matthew Broadbent
P2860
P304
P356
10.1093/SCHBUL/SBU120
P407
P577
2014-08-25T00:00:00Z